Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

AIDS

Volumn 25, Issue 6, 2011, Pages 761-766

  Labarga, Pablo ^a   Soriano, Vincent ^a   Caruz, Antonio ^b   Poveda, Eva ^a   Di Lello, Frederico ^c   Hernandez Quero, Jose ^d   Moreno, Santiago ^e   Bernal, Enrique ^f   Miró, José M ^g   Leal, Manuel ^h   Gutierrez, Felix ⁱ   Portilla, Joaquín ^j   Pineda, Juan A ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

more..

Author keywords

hepatitis C; hepatitis C virus; HIV; IL28B; viremia

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 28B; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ALLELE; ARTICLE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SPAIN; VIREMIA; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON ALFA-2B; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, VIRAL; VIRAL LOAD; VIREMIA;

EID: 79953731812     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834488e7     Document Type: Article

References (22)

1. Ge D, Fellay J, Thompson A, Simon J, Shianna K, Urban T, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461:399-401.
2. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009; 41:1100-1104.
3. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41:1105-1109.
4. Thomas D, Thio C, Martin M, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
5. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-1345.
6. McCarthy J, Li J, Thompson A, Suchindran S, Lao XQ, Patel K, et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 2010; 138:2307-2314.
7. Montes-Cano MA, Garcia-Lozano JR, Abad-Molina C, Romero-Gómez M, Barroso N, Aguilar-Reina J, et al. Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 2010; 52:33-37.
8. Mangia A, Thompson A, Santoro R, Piazzolla V, Tillmann H, Patel K, et al. An IL28B polymorphism determines treatment response of hepatitis C virus genotypes 2 or 3 patients who do not achieve a rapid virologic response. Gastroenterology 2010; 139:821-827.
9. Tillmann H, Thompson A, Patel K, Wiese M, Tenckhoff H, Nischalke H, et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 2010; 139:1586-1592.
10. Rallon N, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, et al. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. AIDS 2010; 24:F23-F29.
11. Pineda JA, Caruz A, Rivero A, Neukam K, Salas I, Camacho A, et al. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2010; 51:788-795.
12. Balagopal A, Thomas D, Thio C. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010; 139:1865-1876.
13. Thompson A, Muir A, Sulkowski M, Ge D, Fellay J, Shianna K, et al. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology 2010; 139:120-129.
14. Thompson A, Clark P, Fellay J, Muir A, Tillmann H, Patel K, et al. IL28B genotype is not associated with advanced hepatic fibrosis in chronic hepatitis C patients enrolled in the IDEAL study [abstract]. Hepatology 2010; 52:A229.
15. Bitetto D, Fabris C, Fornasiere E, Fumolo E, Cussigh A, Bignulin S, et al. IL28B RS12979860 C>T polymorphism affects the evolution of chronic hepatitis C [abstract]. Hepatology 2010; 52:A230.
16. Sherman K, Shire N, Cernohous P, Rouster S, Omachi J, Brun S, et al. Liver injury and changes in hepatitis C virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Clin Infect Dis 2005; 41:1186-1195. (Pubitemid 41429484)
17. Pérez-Cachafeiro S, Del Amo J, Iribarren JA, Salavert M, Gutiérrez F, Moreno A, et al. Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006. Clin Infect Dis 2009; 48: 1467-1470.
18. García-Merino I, de Las Cuevas N, Jiménez JL, Gallego J, Gómez C, Prieto C, et al. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 2009; 6:27.
19. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 2009; 4:e8209.
20. Livak K. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14:143-149. (Pubitemid 29095371)
21. Urban T, Thompson A, Bradrick S, Fellay J, Schuppan D, Cronin K, et al. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 2010; 52:1888-1896.
22. Barreiro P, Pineda JA, Rallon N, Naggie S, Martin-Carbonero L, Neukam K, et al. Influence of interleukin-28B single nucleotide polymorphisms on progression to liver cirrhosis in HIV/hepatitis C virus coinfected patients on antiretroviral therapy. J Infect Dis (in press).